Hot penny stocks... don't get burned
   

News for Vion Pharmaceuticals (VION)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Vion Pharmaceuticals Inc.  (VION) 
|
$ 0.37      0.01 (+2.78%) Volume: 19.48 k 1:29 PM EDT Oct 7, 2008
Mon, Sep 22, 2008
8:01 AM Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients - PR Newswire
Tue, Aug 19, 2008
8:02 AM Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy - PR Newswire
Thu, Aug 14, 2008
4:30 PM Vion Pharmaceuticals is Delisted from Nasdaq Stock Market - PR Newswire
Mon, Aug 04, 2008
5:00 PM Vion Reports 2008 Second Quarter and Six-Month Results - PR Newswire
Fri, Jun 13, 2008
3:30 AM Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting - PR Newswire
Mon, Jun 02, 2008
3:06 PM Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting - PR Newswire
9:20 AM BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR - PR Newswire
7:30 AM Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting - PR Newswire
Fri, May 30, 2008
8:01 AM Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting - PR Newswire
Thu, May 08, 2008
8:03 AM Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine - PR Newswire
7:45 AM Vion Pharmaceuticals to Appeal Nasdaq Delisting - PR Newswire
Tue, May 06, 2008
8:01 AM Vion Pharmaceuticals to Host Conference Call to Discuss 2008 First Quarter Financial Results - PR Newswire
Mon, May 05, 2008
4:30 PM Vion Reports 2008 First Quarter Results - PR Newswire
Tue, Apr 15, 2008
4:30 PM Vion Pharmaceuticals Files Plan With Nasdaq - PR Newswire
Wed, Mar 26, 2008
8:01 AM Vion Pharmaceuticals Receives Nasdaq Notice - PR Newswire
Mon, Mar 17, 2008
8:01 AM Vion Reports 2007 Fourth Quarter and Year-End Results - PR Newswire
Fri, Mar 14, 2008
9:16 AM Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results - PR Newswire
Fri, Mar 07, 2008
8:01 AM Vion Pharmaceuticals Regains NASDAQ Listing Compliance - PR Newswire
Wed, Feb 20, 2008
2:00 PM Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split - PR Newswire
Fri, Feb 15, 2008
5:32 PM Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes - PR Newswire
Wed, Feb 13, 2008
4:15 PM Vion Pharmaceuticals Holds Special Meeting of Stockholders - PR Newswire
Mon, Feb 04, 2008
8:00 AM Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team - PR Newswire
Tue, Jan 08, 2008
8:02 AM Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML - PR Newswire
Mon, Dec 10, 2007
7:30 AM Vion Pharmaceuticals Presents Preliminary Data from its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at ASH Annual Meeting - PR Newswire
Thu, Dec 06, 2007
8:03 AM Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting - PR Newswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for VION stock. Download VION report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download VION report
  
Example preview: Research report for Vion Pharmaceuticals (VION) Research report for Vion Pharmaceuticals (VION) Research report for Vion Pharmaceuticals (VION) Research report for Vion Pharmaceuticals (VION)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Vion Pharmaceuticals
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.